Table 4.
Strategy | Antigens | ||||
---|---|---|---|---|---|
BCG | PENTA | OPV | Measles | YFV | |
Fixed | 37.7% | 6.8% | 15.7% | 27.2% | 27.2% |
Outreach | 50.2% | 7.1% | 9.6% | 38.8% | 38.8% |
Global | 43.0% | 6.9% | 13.5% | 32.6% | 32.6% |
National norm | < 50% | < 5% | < 25% | < 25% | < 25% |
Strategy | Antigens | ||||
---|---|---|---|---|---|
BCG | PENTA | OPV | Measles | YFV | |
Fixed | 37.7% | 6.8% | 15.7% | 27.2% | 27.2% |
Outreach | 50.2% | 7.1% | 9.6% | 38.8% | 38.8% |
Global | 43.0% | 6.9% | 13.5% | 32.6% | 32.6% |
National norm | < 50% | < 5% | < 25% | < 25% | < 25% |